Natus Medical Announces Preliminary Revenue for the First Quarter 2016
Apr 04, 2016 11:00 am UTC| Business
PLEASANTON, Calif., April 04, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced preliminary revenue for is first quarter ended March 31, 2016. Revenue for the first quarter of 2016 is expected to be...
Apr 04, 2016 11:00 am UTC| Business
Obtained FDA clearance in November 2015 for Ablatherm Robotic HIFU;Fourth quarter 2015 HIFU Division revenues tripled over fourth quarter 2014;Overall fourth quarter 2015 revenues increased 82% over 2014 to EUR 11.8...
Plug Power to Exhibit and Host Press Conference at MODEX 2016
Apr 04, 2016 11:00 am UTC| Business
LATHAM, N.Y., April 04, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing clean, reliable energy solutions, today announced it will exhibit and host a press conference at MODEX 2016, happening now through...
Apr 04, 2016 11:00 am UTC| Business
Positive data from Zilretta Phase 2b and Phase 3 clinical trials demonstrate consistent efficacy across both studies with substantial and persistent pain reliefIn the Phase 3 trial Zilretta, in contrast to...
Mitek’s Michael Hagen To Speak at Money20/20 Europe
Apr 04, 2016 11:00 am UTC| Business
SAN DIEGO and HAARLEM, Netherlands, April 04, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, announced that managing director of...
Curis Announces Publication of CUDC-907 Phase 1 Clinical Trial Data in Lancet Oncology
Apr 04, 2016 11:00 am UTC| Business
-- Latest analysis of data presented at the American Society of Hematology’s annual meeting in December, 2015 ---- CUDC-907 demonstrated objective responses, including complete responses, in patients with...
Paratek Announces Completion of Enrollment for Omadacycline Phase 3 Skin Study
Apr 04, 2016 11:00 am UTC| Business
BOSTON, April 04, 2016 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that it has completed enrollment in the pivotal Phase 3 clinical study evaluating omadacycline for the treatment of Acute Bacterial...